Bausch Health Companies (BHC) Minority Interest (2013 - 2026)
Bausch Health Companies (BHC) reported Minority Interest of $977.0 million for Q1 2026, up 3.61% on a YoY basis from $943.0 million in Q1 2025, and up 4.94% sequentially from $931.0 million in Q4 2025.
Bausch Health Companies (BHC) Minority Interest (2013 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 14 years of Minority Interest data on file, last reported at $977.0 million in Q1 2026.
- For the quarter ending Q1 2026, Minority Interest rose 3.61% year-over-year to $977.0 million; the trailing twelve-month figure through Mar 2026 stood at $977.0 million (up 3.61% YoY), and the FY2025 full-year result was $931.0 million, down 2.72% from the prior year.
- Minority Interest grew to $977.0 million in Q1 2026, from $931.0 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $977.0 million in Q1 2026 to a low of $75.0 million in Q1 2022.
- A 5-year average of $891.5 million and a median of $943.0 million in 2025 frame the typical range for Minority Interest.
- Across the five-year window, Minority Interest soared 1288.41% in 2022 and fell 3.9% in 2025, its largest moves.
- Tracing BHC's Minority Interest over 5 years: stood at $952.0 million in 2022, then declined by 1.26% to $940.0 million in 2023, then gained by 1.81% to $957.0 million in 2024, then declined by 2.72% to $931.0 million in 2025, then climbed by 4.94% to $977.0 million in 2026.
- Business Quant data shows BHC's Minority Interest at $977.0 million in Q1 2026, $931.0 million in Q4 2025, and $921.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 977.00 Mn |
| Dec 31, 2025 | 931.00 Mn |
| Sep 30, 2025 | 921.00 Mn |
| Jun 30, 2025 | 911.00 Mn |
| Mar 31, 2025 | 943.00 Mn |
| Dec 31, 2024 | 957.00 Mn |
| Sep 30, 2024 | 932.00 Mn |
| Jun 30, 2024 | 948.00 Mn |
| Mar 31, 2024 | 941.00 Mn |
| Dec 31, 2023 | 940.00 Mn |
| Sep 30, 2023 | 945.00 Mn |
| Jun 30, 2023 | 934.00 Mn |
| Mar 31, 2023 | 945.00 Mn |
| Dec 31, 2022 | 952.00 Mn |
| Sep 30, 2022 | 958.00 Mn |
| Jun 30, 2022 | 946.00 Mn |
| Mar 31, 2022 | 75.00 Mn |
| Dec 31, 2021 | 72.00 Mn |
| Sep 30, 2021 | 69.00 Mn |
| Jun 30, 2021 | 76.00 Mn |